Collaborate with the University of Canterbury on an Industry Project
Have you put off starting a project because you don’t have the time or resources to tackle it right now? Could you benefit from in-depth research or consultancy for your organisation?
The University of Canterbury may be able to help. They want to hear from companies interested in partnering with students on industry projects, covering
- Industrial product design and fibre based research
- Chemical, natural and healthcare product formulation
What’s in it for me?
A collaboration with the University of Canterbury, could help you complete a project you wouldn’t normally have time for.
You’ll be working with innovative and creative students – New Zealand’s future engineers or designers.
When the project is complete, your organisation will have access to the prototype, report, or case study produced by the student(s).
Previous project owners have found value in the often unique and interesting viewpoints students bring to their project(s).
How does it work?
There are opportunities to be involved as a ‘project partner’ or a ‘project sponsor’. As the owner of the project, you’ll set expectations and provide support and direction to your student(s).
You’ll find information about being a project partner in the Masters of Applied Data Science ‘Collaborate’ brochure. This option doesn’t require funding, although you’re encouraged to pay your student for their time.
Almost anything that you want to understand better, and can identify data for, can be submitted as a potential project for students from this programme.
As a project sponsor, you make a financial contribution to the College of Engineering. You can find out more about what’s involved – including costs, timeframes, and a list of potential project areas – in the University of Canterbury’s College of Engineering ‘Collaborate’ brochure.
You’ll also find examples of previous projects on the College of Engineering’s webpage.
There are a range of specialisations within the College of Engineering. NZHIA members may be particularly interested in working with students from the ‘Chemical, Natural, and Healthcare Product Formulation’ programme.
I’m interested – what now?
The deadline for submitting a project partnership proposal is Monday, 30 September 2019.
The deadline for submitting a project sponsorship proposal is Friday, 20 September 2019.
Projects will start in November 2019.
Contact Grahame Burgess at the University of Canterbury or visit the College of Engineering ‘Industry Collaborations’ webpage for more information.
See a list of potential topics
- Industrial product design and fibre based research – here
- Chemical, natural and healthcare product formulation – here
The biggest story behind the, Marijuana Hooplah is the discovery of the Endocannabinoid System (ECS).
The ECS promotes Homeostasis, which is the balance and fine tuning of all of the 11 major physiological systems insuring they are all working in harmony with one another.
That’s why cannabis seems to bring balance to many ailments.
The Endo-cannabinoid System (ECS) is a biological system of receptors and neurotransmitters in the brain, nervous system, organs, glands, immune cells and connective tissue. A healthy ECS will act as the master controlling system for:
Components of the ECS: Cannabinoids, Enzymes, Receptors.
Enzymes: Any substance in the body that causes chemical reactions to occur.
Endocannabinoids are produced naturally inside your body. Phytocannabinoids are produced in nature and at higher levels in the cannabis plant. (Endocannabinoids can be supplemented into the diet through Hemp and Hemp Seed based foods). Whereupon the phytocannabinoids will mimic your missing endocannabinoids. That’s why a well balanced diet will include hemp seed oil and full plant spectrum foods or supplements.
Every time a key (Cannabinoid) fits into a lock (Receptor) the lock causes an effect to occur in the body.
The 2 main endocannabinoids found in the body are:
Anandamide is commonly referred to as ‘the bliss molecule’ and is responsible for runners high and the blissful states that come from structured play, yoga and meditation.
2-AG the most prevalent endocannabinoid is responsible for Appetite, Pain Response and Immune System Functions.
While you were napping in 2003, the US Govt. Department of Health & Human Services registered a patent on Cannabinoids as Antioxidants and Neuroprotectants.
US Patent No: 6,630,507 B1
That’s pretty weird because another branch of the same government the Drug Enforcement Agency (DEA) on the 2nd of Aug 2019, continued to maintain that Cannabis and Cannabinoids would not be rescheduled, stating 3 reasons:
The potential for, and history of abuse and addiction
Lack of accepted medical use
Lack of safety information – Figure that out !?!?!?
Cannabidiol (CBD) is the most abundant cannabinoid naturally present in the industrial hemp plant and it’s extracts.
CBD is non psychotropic, non-intoxicating, non-addictive and very well tolerated by humans, even in large doses.
At least 113 different cannabinoids have been isolated from the cannabis plant.
The most studied cannabinoids include tetrahydrocannabinol (THC) and cannabidiol (CBD).
Hemp extracts are used in food/supplements for their health maintaining properties.
Hemp extracts include valuable phyto-nutrients like Terpenes and Flavonoids. They are also part of the CBD Economy.
Terpenes provide the aroma of the plant and flavinoids provide taste.
The Ministry of Health has opened public consultation on the proposals for the medicinal cannabis regulations needed to support the Medicinal Cannabis Scheme. Consultation closes Wednesday 7 August 2019 at 5 pm.
Next steps after the consultation
The Ministry of Health will analyse the feedback and consult with the Medicinal Cannabis Advisory Group before providing advice to the Government on the outcomes of the consultation, including any proposed changes. The Ministry of Health will then seek approval from Cabinet on the regulatory proposals and work with the Parliamentary Counsel Office to draft the proposed Misuse of Drugs (Medicinal Cannabis) Regulations.
We are aiming to have the above regulations made by 18 December 2019 and to have the Medicinal Cannabis Scheme operational in the first quarter of 2020.